Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;79(12):3528-3533.
doi: 10.1111/all.16198. Epub 2024 Jun 16.

Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy

Affiliations

Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy

Daniel P Cook et al. Allergy. 2024 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this manuscript.

Figures

FIGURE 1
FIGURE 1
T2 inflammation exists as an endotype of CF and is associated with decreased pulmonary function, greater infections with hallmark CF pathogens, increased burden of CF complications and comorbid disease, and decreased survival. (A) A PheWAS Manhattan plot showing enrichment of PheCodes in T2 CF subjects compared to non‐T2 CF subjects. Phecodes (grouped by category) are on the x‐axis and the −log10 (p‐value) is on the y‐axis. The red line reflects the Bonferroni threshold (1.58 × 10−4). Top hits from Infectious Diseases, Hematopoietic, and Respiratory chapters are annotated. For each hit, an upward pointing triangle represents a positive association with T2 signature in CF (OR greater than 1), and a lighter shaded downward pointing triangle represents a negative association (OR <1). Each color corresponded to the annotated category on the x‐axis. (B) Histogram distribution of highest lifetime FEV1/FVC ratio values in non‐T2 CF subjects compared to T2 CF subjects (n = 376). Solid line represents mean and dashed line represents interquartile range. p‐values of comparisons of non‐T2 CF to T2 CF are listed on lower graph. (C) Kaplan–Meier estimate of survival probability comparing T2 CF subjects (dark blue) with non‐T2 CF (light blue) subjects. Among all adults surviving to age 18, overall survival was significantly lower based on T2 status, with 61% (95% CI: 53% to 71%) of T2 CF versus 77% (95% CI: 65% to 90%) of non‐T2 CF reaching age 50 years old (p = 0.013 by Log‐rank test). Number of surviving in the electronic health record (at risk) and dead (events) are shown in the decade lower table at each decade (20–60). FEV1, forced expiratory volume in the first second; FVC, forced vital capacity. (D, E) Waterfall plots of percent change in total serum IgE levels in CF subjects treated with CFTR modulator therapy. Serum IgE percent change following initiation of modulator therapy in individuals receiving (D) highly effective CFTR modulator therapy (ETI or Ivacaftor in patients with a gating mutation, n = 155) and (E) non highly effective CFTR modulator therapy (Lumacaftor/Ivacaftor or Tezacaftor/Ivacaftor, or Ivacaftor in patients without a gating mutation, n = 59). p‐values are displayed on corresponding graph.

References

    1. Gothe F, Kappler M, Griese M. Changes in total IgE levels predict pulmonary outcome in cystic fibrosis related allergic bronchopulmonary aspergillosis. Eur Respir J. 2016;48(suppl 60):PA1259.
    1. Allard JB, Poynter ME, Marr KA, Cohn L, Rincon M, Whittaker LA. Aspergillus fumigatus generates an enhanced Th2‐biased immune response in mice with defective cystic fibrosis transmembrane conductance regulator. J Immunol. 2006;177(8):5186‐5194. - PubMed
    1. Mueller C, Braag SA, Keeler A, Hodges C, Drumm M, Flotte TR. Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses. Am J Respir Cell Mol Biol. 2011;44(6):922‐929. - PMC - PubMed
    1. Albon D, Zhang L, Patrie J, et al. Association between cystic fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization. Allergy Asthma Clin Immunol. 2023;19(1):15. - PMC - PubMed
    1. Moss RB, Hsu YP, Olds L. Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes. Clin Exp Immunol. 2000;120(3):518‐525. - PMC - PubMed

LinkOut - more resources